Login / Signup

Long-term Remission in Functioning Pituitary Adenomas after Medical Therapy Withdrawal: A Chance for Cushing's Disease.

Alessandro MondinFilippo CeccatoCarla ScaroniMattia Barbot
Published in: Endocrine, metabolic & immune disorders drug targets (2024)
Far from the general rule, this case suggests that prolonged treatment with pasireotide LAR might induce a durable CD remission. A dose down-titration/suspension might be considered in patients well-controlled on long-term therapy and with negative pituitary imaging. However, close monitoring is recommended given the high rate of complications in untreated patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • healthcare
  • peritoneal dialysis
  • patient reported
  • growth hormone